Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin

被引:123
作者
Bosnar, M [1 ]
Kelneric, Z [1 ]
Munic, V [1 ]
Erakovic, V [1 ]
Parnham, MJ [1 ]
机构
[1] PLIVA Res Inst Ltd, HR-1000 Zagreb, Croatia
关键词
D O I
10.1128/AAC.49.6.2372-2377.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Macrolide antibiotics have an outstanding ability to concentrate within host cells, particularly phagocytes. In the study described in this paper five different macrolide antibiotics were compared regarding the uptake and release kinetics in human peripheral blood polymorphonuclear neutrophils (PMNs) and three different cell lines, two phagocytic cell lines (RAW 264.7 and THP-1) and an epithelial cell line (MDCK). Based on the results obtained, the substances tested could be clustered into different groups. Azithromycin constituted the first group, characterized by rapid and nonsaturable uptake into phagocytic cells and a high degree of retention in the preloaded cells. The second group included erythromycin and clarithromycin. These two substances do not exhibit cell specificity; consequently, they are taken up to a similar extent and are released by all cell types studied. Ketolides constituted the last group. Their uptake was saturable in cells of monocytic lineage as well as in nondifferentiated cells of myeloid lineage, and they were rapidly released from all the cell lines studied. However, in PMNs, ketolide uptake was, not saturable; and unlike telithromycin, cethromycin rapidly egressed from the loaded cells.
引用
收藏
页码:2372 / 2377
页数:6
相关论文
共 35 条
[1]   Interaction of macrolides and ketolides with the phagocytic cell line PLB-985 [J].
Abdelghaffar, H ;
Soukri, A ;
Babin-Chevaye, C ;
Labro, MT .
JOURNAL OF CHEMOTHERAPY, 2003, 15 (04) :350-356
[2]   AZITHROMYCIN UPTAKE AND INTRACELLULAR ACCUMULATION BY TOXOPLASMA GONDII-INFECTED MACROPHAGES [J].
BLAIS, J ;
BEAUCHAMP, D ;
CHAMBERLAND, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (03) :371-382
[3]   SYNTHESIS, INVITRO AND INVIVO ACTIVITY OF NOVEL 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN A DERIVATIVES - A NEW CLASS OF MACROLIDE ANTIBIOTICS, THE AZALIDES [J].
BRIGHT, GM ;
NAGEL, AA ;
BORDNER, J ;
DESAI, KA ;
DIBRINO, JN ;
NOWAKOWSKA, J ;
VINCENT, L ;
WATROUS, RM ;
SCIAVOLINO, FC ;
ENGLISH, AR ;
RETSEMA, JA ;
ANDERSON, MR ;
BRENNAN, LA ;
BOROVOY, RJ ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
GIRARD, AE ;
GIRARD, D ;
HERBERT, C ;
MANOUSOS, M ;
MASON, R .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1029-1047
[4]  
CARLIER MB, 1994, INT J TISSUE REACT, V16, P211
[5]   Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin [J].
Conte, JE ;
Golden, JA ;
Kipps, J ;
Zurlinden, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3508-3515
[6]   Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens [J].
Denis, A ;
Agouridas, C ;
Auger, JM ;
Benedetti, Y ;
Bonnefoy, A ;
Bretin, F ;
Chantot, JF ;
Dussarat, A ;
Fromentin, C ;
D'Ambrières, SG ;
Lachaud, S ;
Laurin, P ;
Le Martret, O ;
Loyau, V ;
Tessot, N ;
Pejac, JM ;
Perron, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (21) :3075-3080
[7]   THE PHARMACOKINETICS OF AZITHROMYCIN IN HUMAN SERUM AND TISSUES [J].
FOULDS, G ;
SHEPARD, RM ;
JOHNSON, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :73-82
[8]   INVITRO DEMONSTRATION OF TRANSPORT AND DELIVERY OF ANTIBIOTICS BY POLYMORPHONUCLEAR LEUKOCYTES [J].
FRANK, MO ;
SULLIVAN, GW ;
CARPER, HT ;
MANDELL, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2584-2588
[9]   INVITRO AND INVIVO UPTAKE OF AZITHROMYCIN (CP-62,993) BY PHAGOCYTIC-CELLS - POSSIBLE MECHANISM OF DELIVERY AND RELEASE AT SITES OF INFECTION [J].
GLADUE, RP ;
BRIGHT, GM ;
ISAACSON, RE ;
NEWBORG, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) :277-282
[10]   Disposition and intracellular activity of azithromycin in human THP-1 acute monocytes [J].
Hall, IH ;
Schwab, UE ;
Ward, ES ;
Butts, JD ;
Wolford, ET ;
Ives, TJ .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (05) :348-360